Vimarsana
Biggest News Aggregation in the World

Page 4 - Eric Rojas News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Eric Rojas. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Eric Rojas Today - Breaking & Trending Today

Michael Sandrock: Marc Hunter's legacy endures - Vimarsana News

Michael Sandrock: Marc Hunter's legacy endures

Marc Hunter's 1980 win shows the paradox of racing the Bolder Boulder most efficiently — and any long distance race — going out slower can make you faster.

Stoke Therapeutics : Data readout will focus on safety and seizure frequency results for up to 16 patients who received three doses of 45mg of STK-001 - Form 8-K - Vimarsana News

Stoke Therapeutics : Data readout will focus on safety and seizure frequency results for up to 16 patients who received three doses of 45mg of STK-001 - Form 8-K

- Data readout will focus on safety and seizure frequency results for up to 16 patients who received three doses of 45mg of STK-001 - - Company plans to initiate a pivotal study... | May 4, 2023

Stoke Therapeutics Reports First Quarter Financial Results and Provides Business Updates - Vimarsana News

Stoke Therapeutics Reports First Quarter Financial Results and Provides Business Updates

– Company on-track to report new data from the ongoing Phase 1/2a clinical studies of STK-001 in children and adolescents with Dravet syndrome in mid-2023 – – Data readout will focus on safety and seizure frequency results for up to 16 patients who received three doses of 45mg of STK-001 –– Company plans to initiate...

Stoke Therapeutics, Inc.: Stoke Therapeutics Receives Authorization to Initiate a Phase 1/2 Study of STK-002 for Autosomal Dominant Optic Atrophy (ADOA) in the United Kingdom - Vimarsana News

Stoke Therapeutics, Inc.: Stoke Therapeutics Receives Authorization to Initiate a Phase 1/2 Study of STK-002 for Autosomal Dominant Optic Atrophy (ADOA) in the United Kingdom

- Company advancing second TANGO ASO into the clinic - - STK-002 has the potential to be the first disease-modifying therapy to address the root cause of ADOA, the most common inherited optic nerve

Why Bad Bunny's "un x100to" marks a turning point for regional Mexican music : NPR - Vimarsana News

Why Bad Bunny's "un x100to" marks a turning point for regional Mexican music : NPR

This week a collaboration between Bad Bunny and Grupo Frontera, in addition to a historic chart placement for Mexican artist Peso Pluma, pushed regional Mexican music to international attention

Source: npr.org